ADMA - ADMA Biologics GAAP EPS of -$0.09 beats by $0.01 revenue of $26.38M beats by $4.61M March, 24 2022 04:19 PM ADMA Biologics Inc ADMA Biologics press release (NASDAQ:ADMA): Q4 GAAP EPS of -$0.09 beats by $0.01. Revenue of $26.38M (+89.0% Y/Y) beats by $4.61M. Shares +3.3%. For further details see: ADMA Biologics GAAP EPS of -$0.09 beats by $0.01, revenue of $26.38M beats by $4.61M